NO CALL ON RECORD
the engine publishes a call only when every gate clears
SEE THE LEDGER →FINNENCE ▪ THE ASSET FILE
PERMANENT ASSET RECORD · TRACKED BY FINNENCE
LLY
Eli Lilly
$1,170.14
LAST CLOSE2026-09-22 · +0.5%Eli Lilly — 41 stories tracked over the last 30 days. No call on record.
LAST $1,170.14·Δ1D +0.5%·Δ20D -6.2%·60D RANGE $1,114.08–$1,280.34·FROM 60D HIGH -8.6%·THEMES 1
SECTION 01 · THE MACHINE'S FILE
WHAT FINNENCE THINKS.
NO OPEN PAPER POSITION
the $1K paper fund holds nothing here
VIEW THE PAPER FUND →THEME CONTEXT
Healthcare
EMERGINGMEMBER · SCORE 0.424
RS20 -0.077079
NO ABNORMAL MOVES FLAGGED IN THE LAST 45 DAYS
the scanner re-runs hourly; flags land on the radar
ON THE RADAR →SECTION 02 · THE PRICE RECORD
NINETY SESSIONS, ONE LINE.
LAST$1,170.14Δ1D+0.5%Δ20D-6.2%60D RANGE$1,114.08–$1,280.34
INTERACTIVE PRICE — TRADINGVIEW
INTERACTIVE CHART — LOADS WHEN VISIBLE
SECTION 03 · THE STORY FLOW
WHAT THE FEED SAW.
Recent stories2026-09-22 15:46 UTCNEWSBULLISHThis GLP-1 drug helped people maintain their weight loss in a clinical trial — even for those taking it once a month
2026-09-22 08:53 UTCNEWSMIXEDNovo defends diversification push as CEO eyes deals beyond obesity - CNBC
2026-09-22 04:00 UTCNEWSBULLISHBoomRay Enters Exclusive Global License Agreement with Novartis for a Novel Radioligand Therapy Asset
2026-09-21 22:58 UTCNEWSUNCLEARTrump admin reportedly considers NIH grant approval takeover - thehill.com
2026-09-21 21:40 UTCNEWSBULLISHLilly breaks ground in Houston, one of ten U.S. manufacturing sites announced since 2020
2026-09-21 19:43 UTCNEWSMIXEDModerna will reveal the data for its mRNA cancer vaccine next month. Here’s why it matters.
2026-09-21 18:28 UTCNEWSBULLISHEli Lilly CEO says 700,000 new seniors have started GLP-1s after Medicare coverage, and 70% are on Lilly drugs
2026-09-21 17:14 UTCNEWSBULLISHEli Lilly CEO tells CNBC one-third of new GLP-1 pill patients are taking Foundayo, as drugmaker ramps up production
2026-09-21 14:31 UTCNEWSBULLISHCancer Vaccines Market Anticipates Impressive Growth Trajectory at a CAGR of 36% During the Forecast Period (2026-2036) | DelveInsight
2026-09-21 08:29 UTCNEWSBULLISHRetension and Lilly-backed TRex Bio both set out plans to join biotech IPO stampede - fiercebiotech.com
SECTION 04 · CATALYSTS
2026-10-29 00:00 UTCEARNINGS
LATEST PRICES
2026-09-22 00:00 UTCyfinance$1,153.30 -0.0%
2026-09-21 00:00 UTCyfinance$1,152.49 -0.0%
2026-09-18 00:00 UTCyfinance$1,152.03 -0.0%
2026-09-17 00:00 UTCyfinance$1,158.26 +0.0%
2026-09-16 00:00 UTCyfinance$1,144.85 +0.0%
2026-09-15 00:00 UTCyfinance$1,146.95 +0.0%
2026-09-14 00:00 UTCyfinance$1,136.69 +0.0%
2026-09-11 00:00 UTCyfinance$1,119.90 -0.0%
METHODOLOGY · PAPER ONLY
OPEN THE MACHINE →A permanent, data-backed asset record. Calls are immutable; market data and machine detections update. PAPER ONLY · NOT FINANCIAL ADVICE.
INSPECT THE PAPER FUND →